Research

Hormonal

Tirzepatide is associated with a lower prevalence of gastrointestinal and systemic adverse events compared to semaglutide, particularly in high responders.

If you are concerned about side effects like nausea or vomiting, Tirzepatide may be better tolerated than Semaglutide in real-world use, especially if you are a 'high responder' to the drug.

GoodSupportsHIGH confidence
AI-enabled curation showed that tirzepatide was associated with lower prevalence of gastrointestinal and systemic adverse events.
AJ Venkatakrishnan et al. · medRxiv · 2025

Why this rating

Large cohort, but AE data derived from unstructured clinical notes via AI, which may have ascertainment bias.

Source

Weight Loss Dynamics and Health Burden Changes with Tirzepatide versus Semaglutide

AJ Venkatakrishnan et al. · medRxiv · 2025

DOI 10.64898/2025.11.30.25341294

preprint · n=20678Cited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →